Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

21

Revenue 2014

Otsuka

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.

Lundbeck partners with IBM Watson on drug research

Lundbeck partners with IBM Watson on drug research

The deal will also see it set up a new real world evidence platform

Deal Watch December 2016

Deal Watch December 2016 1, 000. Akebia (US). Otsuka (Japan). Licence (US). Vadadustat: oral hypoxia-inducible factor (HIF) stabiliser in phase III for anaemia of chronic kidney disease. ... 400. X-Chem (US). Taiho/ Otsuka (Japan). Discovery collaboration &licence. Access to DEX

Ashley Communications celebrates 20 years of medical communications

Ashley Communications celebrates 20 years of medical communications Among this number are big pharma firmsand Merck &Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax

Lundbeck trial failure dashes hopes in Alzheimer's once again

Lundbeck trial failure dashes hopes in Alzheimer's once again Idalopirdine is being developed in partnership with Japanese drugmaker Otsuka. The news wreaked havoc on the shares of Axovant, another company developing a 5-HT6 inhibitor for Alzheimer's.

Surging sales of Lundbeck's CNS drugs assist recovery

Surging sales of Lundbeck's CNS drugs assist recovery Meanwhile, Otsuka-partnered Rexulti - which made its debut as an add-on treatment for major depression and schizophrenia in the US a year ago - added another DKK193m. ... new Otsuka-partnered drug - idalopirdine - in trials for Alzheimer's disease.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics